Study of BIIB092 in Participants With Progressive Supranuclear Palsy

PHASE2TerminatedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

September 6, 2019

Study Completion Date

February 7, 2020

Conditions
Supranuclear Palsy, Progressive
Interventions
DRUG

BIIB092

BIIB092 intravenous infusion on specified days

DRUG

Placebo

Placebo intravenous infusion on specified days

Trial Locations (86)

10029

Research Site, New York

12208

Research Site, Albany

17033

Research Site, Hershey

19104

Research Site, Philadelphia

21201

Research Site, Baltimore

21287

Research Site, Baltimore

29425

Research Site, Charleston

32607

Research Site, Gainesville

33486

Research Site, Boca Raton

48334

Research Site, Farmington Hills

60611

Research Site, Chicago

66160

Research Site, Kansas City

85013

Research Site, Phoenix

85259

Research Site, Scottsdale

85351

Research Site, Sun City

90095

Research Site, Los Angeles

92037

Research Site, La Jolla

92708

Research Site, Fountain Valley

94158

Research Site, San Francisco

98122

Research Site, Seattle

100029

Research Site, New York

33612-4742

Research Site, Tampa

60612-3841

Research Name, Chicago

60637-1447

Research Site, Chicago

46202-2280

Research Site, Indianapolis

70121-2429

Research Site, New Orleans

02114

Research Site, Boston

01702

Research Site, Burlington

55455-0341

Research Site, Minneapolis

08901

Research Site, New Brunswick

10032-3725

Research Site, New York

75390-8869

Research Site, Dallas

22908-0394

Research Site, Charlottesville

Unknown

Research Site, North Melbourne

Research Site, Innsbruck

Research Site, Vienna

Research Site, London

Research Site, Ottawa

Research Site, Toronto

Research Site, Bordeaux

Research Site, Lille

Research Site, Marseille

Research Site, Nîmes

Research Site, Paris

Research Site, Rennes

Research Site, Toulouse

Research Site, Munich

Research Site, Marburg

Research Site, Rostock

Research Site, Düsseldorf

Research Site, Dresden

Research Site, Kiel

Research Site, Lübeck

Research Site, Beelitz-Heilstätten

Research Site, Bochum

Research Site, Bonn

Research Site, Essen

Research Site, Kassel

Research Site, Ulm

Research Site, Athens

Research Site, Salerno

Research Site, Pisa

Research Site, Venice-Lido

Research Site, Nagoya

Research Site, Kamagaya

Research Site, Sapporo

Research Site, Sagamihara

Research Site, Kodaira

Research Site, Yonago

Research Site, Shizuoka

Research Site, Krasnoyarsk

Research Site, Moscow

Research Site, Seoul

Research Site, Pamplona

Research Site, Barakaldo

Research Site, Barcelona

Research Site, Madrid

Research Site, Seville

Research Site, Valencia

Research Site, Cambridge

Research Site, Brighton

Research Site, Southampton

Research Site, Liverpool

Research Site, Newcastle upon Tyne

Research Site, Newport

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY